PRKDC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.666200E-01
Normal-vs-Stage2
7.104800E-01
Normal-vs-Stage3
1.309810E-01
Normal-vs-Stage4
9.607200E-01
Stage1-vs-Stage2
7.364000E-01
Stage1-vs-Stage3
7.393700E-02
Stage1-vs-Stage4
3.459200E-01
Stage2-vs-Stage3
1.634440E-01
Stage2-vs-Stage4
6.200400E-01
Stage3-vs-Stage4
6.488000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.827200E-01
Normal-vs-AfricanAmerican
9.197400E-01
Normal-vs-Asian
2.721400E-01
Caucasian-vs-AfricanAmerican
6.907400E-01
Caucasian-vs-Asian
2.036200E-01
AfricanAmerican-vs-Asian
2.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.340800E-01
Normal-vs-Female
7.639200E-01
Male-vs-Female
4.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.545600E-01
Normal-vs-Age(41-60Yrs)
8.766800E-01
Normal-vs-Age(61-80Yrs)
5.902200E-01
Normal-vs-Age(81-100Yrs)
9.429000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.361600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.023000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.705400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.235170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.728800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.055200E-01
Normal-vs-Daily Drinker
5.275800E-01
Normal-vs-Weekly Drinker
6.219800E-01
Normal-vs-Occasional Drinker
9.807600E-01
Normal-vs-Social Drinker
8.619000E-01
Non Drinker-vs-Daily Drinker
6.777000E-01
Non Drinker-vs-Weekly Drinker
9.602000E-01
Non Drinker-vs-Occasional Drinker
3.090600E-01
Non Drinker-vs-Social Drinker
5.559000E-01
Daily Drinker-vs-Weekly Drinker
6.992600E-01
Daily Drinker-vs-Occasional Drinker
2.081600E-01
Daily Drinker-vs-Social Drinker
3.977800E-01
Weekly Drinker-vs-Occasional Drinker
3.981600E-01
Weekly Drinker-vs-Social Drinker
6.405400E-01
Occasional Drinker-vs-Social Drinker
7.654600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.882800E-01
Normal-vs-Grade 2
9.124000E-01
Normal-vs-Grade 3
5.334200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.236600E-01
Grade 1-vs-Grade 3
4.362500E-02
Grade 1-vs-Grade 4
9.882800E-01
Grade 2-vs-Grade 3
8.662400E-02
Grade 2-vs-Grade 4
9.124000E-01
Grade 3-vs-Grade 4
5.334200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.035200E-01
Normal-vs-NonDiabetic
5.205200E-01
Diabetic-vs-NonDiabetic
6.456200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.466800E-01
Normal-vs-NoPancreatitis
6.453600E-01
Pancreatitis-vs-NoPancreatitis
7.297800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.526800E-01
Normal-vs-N1
7.336800E-01
N0-vs-N1
7.416800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.221400E-01
Normal-vs-TP53-NonMutant
6.622200E-01
TP53-Mutant-vs-TP53-NonMutant
9.862500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
